MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Lin ZY, Chen G, Zhang YQ, He HC, Liang YX, Ye JH, Liang YK, Mo RJ, Lu JM, Zhuo YJ, Zheng Y, Jiang FN, Han ZD, Wu SL, Zhong WD, Wu CL.
Lin ZY, et al. Among authors: liang yx, liang yk.
Mol Cancer. 2017 Feb 27;16(1):48. doi: 10.1186/s12943-017-0615-x.
Mol Cancer. 2017.
PMID: 28241827
Free PMC article.
Retracted.